Home
Browse
Search
Statistics
About
Usage
PMID: 11100963
Choo-Kang LR, Zeitlin PL
Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy.
Curr Opin Pulm Med. 2000 Nov;6(6):521-9.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
22
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 11100963:22:30
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 11100963:22:38
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11100963:22:23
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 11100963:22:70
status:
NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Gln39*
X
ABCC7 p.Gln39* 11100963:22:45
status:
NEW
view ABCC7 p.Gln39* details
ABCC7 p.Arg75*
X
ABCC7 p.Arg75* 11100963:22:57
status:
NEW
view ABCC7 p.Arg75* details
ABCC7 p.Ser1196*
X
ABCC7 p.Ser1196* 11100963:22:82
status:
NEW
view ABCC7 p.Ser1196* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 11100963:22:51
status:
NEW
view ABCC7 p.Glu60* details
ABCC7 p.Leu719*
X
ABCC7 p.Leu719* 11100963:22:63
status:
NEW
view ABCC7 p.Leu719* details
The nonsense mutations
G542X
,
W1282X
,
R553X
,
Q39X
,
E60X
,
R75X
,
L719X
,
Y1092X
, and
S1196X
significantly reduce the levels of mutant CFTR mRNA to 5 to 30% of wild-type levels [28].
Login to comment
31
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 11100963:31:43
status:
NEW
view ABCC7 p.Trp1282* details
Interestingly, one patient who carried the
W1282X
/3849 + 10kbC→T genotype showed complete normalization of chloride transport on NPD following gentamicin administration [31••].
Login to comment
37
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:37:490
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:37:491
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:37:603
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:37:604
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:37:732
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:37:733
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 11100963:37:345
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 11100963:37:346
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11100963:37:163
status:
NEW
view ABCC7 p.Gly542* details
Molecular fate of CFTR protein Type of genetic defect and example Class-specific potential therapeutic approach Specific clinical examples I No synthesis Nonsense
G542X
Frameshift 394delTT Splice junction 1717-1G→A Aminoglycoside readthrough of premature termination site Gentamicin II Trafficking block AA deletion ∆F508 Missense
N1303K
Manipulation of intracellular folding environment (chemical or molecular chaperones) Phenylbutyrate, CPX III Block in regulation Missense
G551D
Stimulation of membrane localized mutant channel Genistein, MPB- compounds IV Altered conductance Missense
R117H
Augmentation of mutant channel conductance Milrinone, adenosine nucleotides V Reduced synthesis of normal protein Missense
A455E
Alternative splicing 3849+10kbC→T Maximal activation of decreased but functionally normal channels Stimulation of mRNA and protein synthesis ?
Login to comment
52
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 11100963:52:76
status:
NEW
view ABCC7 p.Gly480Cys details
Since "misfolding" of the ∆F508 CFTR and other class II mutants (eg,
G480C
) does not completely abolish CFTR chloride conductance [44-46], therapies can be aimed primarily at overcoming the trafficking block, thereby permitting surface expression of the partially active mutant channel.
Login to comment
89
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:89:0
status:
NEW
view ABCC7 p.Gly551Asp details
G551D
is localized at the cell surface but exhibits impaired ATP binding and does not conduct chloride in response to elevated cAMP [71,72].
Login to comment
90
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:90:0
status:
NEW
view ABCC7 p.Gly551Asp details
G551D
is typically associated with pancreatic insufficiency and a severe phenotype.
Login to comment
92
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11100963:92:33
status:
NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 11100963:92:40
status:
NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11100963:92:52
status:
NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 11100963:92:25
status:
NEW
view ABCC7 p.Ser1255Pro details
These mutants, including
S1255P
,
G551S
,
G1244E
, and
G1349D
, sustain a reduced response to ATP.
Login to comment
97
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:97:59
status:
NEW
view ABCC7 p.Gly551Asp details
In a small study of five CF patients carrying at least one
G551D
mutation, perfusion of the nasal mucosa with genistein stimulated chloride-dependent NPD to an average of 16.9% of the responses found in healthy subjects [77••].
Login to comment
106
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:106:29
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 11100963:106:43
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 11100963:106:54
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Gly314Glu
X
ABCC7 p.Gly314Glu 11100963:106:36
status:
NEW
view ABCC7 p.Gly314Glu details
These CFTR mutants including
R117H
,
G314E
,
R334W
, and
R347P
demonstrate a reduction in their chloride conductance or abnormal channel gating (see Fig. 2).
Login to comment
108
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:108:49
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 11100963:108:59
status:
NEW
view ABCC7 p.Pro574His details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 11100963:108:0
status:
NEW
view ABCC7 p.Arg347Pro details
R347P
affects the rate of chloride flow, whereas
R117H
and
P574H
reduce the channel open time.
Login to comment
113
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:113:127
status:
NEW
view ABCC7 p.Gly551Asp details
Although a recent study failed to demonstrate a significant effect of milrinone on chloride secretion in both ∆F508 and
G551D
CF patients [83], phosphodiesterase inhibitors such as rolipram, papaverine, and IBMX (3-isobutyl-1- methyxanthine) may still be beneficial for less stringent mutations.
Login to comment
114
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:114:12
status:
NEW
view ABCC7 p.Arg117His details
In a murine
R117H
model, milrinone in combination with foskolin resulted in a favorable NPD measurement change [84].
Login to comment
116
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:116:133
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:116:140
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11100963:116:151
status:
NEW
view ABCC7 p.Gly1349Asp details
Through this mechanism, adenosine indirectly activates wild-type as well as several surface-localized mutant CFTR channels including
R117H
,
A455E
, and
G1349D
.
Login to comment
117
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:117:65
status:
NEW
view ABCC7 p.Gly551Asp details
Adenosine combined with rolipram or papaverine can also activate
G551D
CFTR measured by halide efflux to approximately 30% of wild-type activity [86].
Login to comment
124
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 11100963:124:53
status:
NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:124:63
status:
NEW
view ABCC7 p.Ala455Glu details
Missense mutations that belong to this class include
P574H
and
A455E
.
Login to comment